The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2008Evaluation of Gastrointestinal Motility in Parkinsonian Rodents
Objective/Rationale:
Gastrointestinal (GI) symptoms, such as nausea, bloating, and constipation occur in nearly every patient afflicted with Parkinson’s Disease (PD) at some point in their illness... -
MJFF Research Grant, 2008Are Anti-Parkinsonian Treatments Disease Modifying?
Objective/Rationale:
Current treatments of Parkinson’s disease are not thought to slow the progression of the disease but just appear to result in temporary relief of symptoms. There is some evidence... -
MJFF Research Grant, 2008QE3 Trial Ancillary Biomarkers Study
Objective/Rationale:
The QE3 trial is a large multicenter clinical trial designed to determine whether the nutritional supplement coenzyme Q10, which traps a potentially dangerous type of chemical in... -
Rapid Response Innovation Awards, 2008Role of Peripheral Enteric Inflammation in Synuclein Pathology in a Murine Model of Parkinson's Disease
Objective/Rationale:
Gastrointestinal dysfunction has long been noted as an early feature of Parkinson’s disease, and “in many cases demands stimulating medicines of very considerable power” (James... -
Rapid Response Innovation Awards, 2008Effects of noradrenergic or serotoninergic system lesions combined with NS lesions on rodent models of 'non-motor'-like symptoms
Objective/Rationale:
Parkinson’s disease is widely attributed to neuropathy of dopaminergic neurones in the nigrostriatal (NS) pathway. Degeneration of noradrenergic and serotonergic neurones in the... -
Cognitive Deficits and Mood Disorders in Parkinson's Disease, 2008Neuroimaging Markers Predict Cognitive Decline in PD
Objective/Rationale:
Isolated cognitive impairments are common in PD; they increase in number and severity with advancing age and motor disability but their relation to the risk of developing dementia...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.